No worries, Tupelo3.

When I wrote those words, I had in the back of my mind the recent discussions about the desirability of speeding up the clinical-trials phase for PD drugs in general. So it wasn't that this one stood out particularly (although it did seem like a good candidate), it was more that I'd lowered the bar!

The question mark at the end was (secret?) code for "I'm interested in a discussion". :-)

But after that, kiwi33 alerted me to some expert comments, which shed new light on things.